Table 4 of Aweidah, Mol Vis 2021; 27:588-600.
Characteristics | Patients with CNGB3 c.1663-1205G>A (Mean±SD; Mean±95% CI) | Patients with other CNGB3 mutations (Mean±SD; Mean±95% CI) | P value |
---|---|---|---|
Age at diagnosis (years) | 7.35±7.93; 7.35±3.77 | 6.42±5.86; 6.42±2.71 | p=0.70 |
Age at first ERG (years) | 7.53±8.26; 7.53±4.18 | 7.58±7.99; 7.58±3.69 | p=0.99 |
Age at the last included ERG (years) | 12.69±9.69; 12.69±5.27 | 15.77±13.43; 15.77±6.80 | p=0.51 |
Age at last included visual acuity (years) | 18.75±12.21; 18.75±5.99 | 20.14±12.02; 20.14±6.30 | p=0.76 |
Current age (years) | 22.82±12.45; 22.82±5.92 | 27.22±17.03; 27.22±7.87 | p=0.41 |
Sex | 9 Males, 8 Females | 9 Males, 9 Females | |
Visual acuity‡ | 0.15±0.07; 0.15±0.034 | 0.092±0.053; 0.092±0.028 | p=0.0215 |
Mean Spherical equivalent§ | −0.58±3.83; −0.58±1.88 | +1.45±2.00; +1.45±1.01 | p=0.088 |
ffERG Cone- Rod response a-wave (μV)§ | 134.94±50.15; 134.94±34.75 | 121.94±37.30; 121.94±25.85 | p=0.59 |
ffERG Cone- Rod response b-wave (μV)§ | 258.81±51.52; 258.81±35.70 | 266.19±37.32; 266.19±25.86 | p=0.76 |
ffERG Rod response (b-wave; μV)§ | 221.36±50.85; 221.36±37.67 | 225.43±68.95; 225.43±51.08 | p=0.91 |